Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venglustat Extension Study in Fabry Disease
NCT02489344Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of venglustat in Fabry disease (FD), sponsored by Sanofi. Started Jul 2015; status: completed.
02
Drugs
venglustat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT02489344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489344.